FRTX Annual SG&A
$11.18 M
-$3.25 M-22.52%
31 December 2023
Summary:
As of January 20, 2025, FRTX annual selling, general & administrative expenses is $11.18 million, with the most recent change of -$3.25 million (-22.52%) on December 31, 2023. During the last 3 years, it has fallen by -$398.00 thousand (-3.44%). FRTX annual SG&A is now -54.37% below its all-time high of $24.51 million, reached on December 1, 2013.FRTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FRTX Quarterly SG&A
$1.64 M
-$3.68 M-69.14%
31 December 2023
Summary:
As of January 20, 2025, FRTX quarterly selling, general & administrative expenses is $1.64 million, with the most recent change of -$3.68 million (-69.14%) on December 31, 2023. Over the past year, it has dropped by -$3.68 million (-69.14%). FRTX quarterly SG&A is now -89.75% below its all-time high of $16.02 million, reached on December 1, 2007.FRTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FRTX TTM SG&A
-$686.86 M
-$5.69 M-0.84%
31 December 2023
Summary:
As of January 20, 2025, FRTX TTM selling, general & administrative expenses is -$686.86 million, with the most recent change of -$5.69 million (-0.84%) on December 31, 2023. Over the past year, it has dropped by -$700.44 million (-5157.89%). FRTX TTM SG&A is now -12165.39% below its all-time high of $29.86 million, reached on September 1, 2012.FRTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FRTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.5% | -69.1% | -5157.9% |
| 3 y3 years | -3.4% | -69.1% | -5157.9% |
| 5 y5 years | +25.1% | -69.1% | -5157.9% |
FRTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.5% | at low | -69.1% | at low | -30.7% | at low |
| 5 y | 5-year | -22.5% | at low | -69.1% | at low | -100.6% | +34.9% |
| alltime | all time | -54.4% | +1298.0% | -89.8% | +125.1% | <-9999.0% | +61.3% |
Fresh Tracks Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $11.18 M(-22.5%) | $1.64 M(-69.1%) | $11.18 M(-17.6%) |
| Sept 2023 | - | $5.32 M(+194.2%) | $13.58 M(+20.6%) |
| June 2023 | - | $1.81 M(-25.1%) | $11.26 M(-15.7%) |
| Mar 2023 | - | $2.41 M(-40.2%) | $13.36 M(-7.4%) |
| Dec 2022 | $14.43 M(+16.2%) | $4.04 M(+34.5%) | $14.43 M(+5.5%) |
| Sept 2022 | - | $3.00 M(-23.2%) | $13.69 M(-1.9%) |
| June 2022 | - | $3.91 M(+12.1%) | $13.95 M(+7.9%) |
| Mar 2022 | - | $3.49 M(+6.0%) | $12.94 M(+4.2%) |
| Dec 2021 | $12.42 M(+7.2%) | - | - |
| Dec 2021 | - | $3.29 M(+0.6%) | $12.42 M(+3.5%) |
| Sept 2021 | - | $3.27 M(+13.1%) | $12.00 M(+0.5%) |
| June 2021 | - | $2.89 M(-2.6%) | $11.94 M(-1.1%) |
| Mar 2021 | - | $2.97 M(+3.4%) | $12.07 M(+4.2%) |
| Dec 2020 | $11.58 M(-4.8%) | $2.87 M(-10.7%) | $11.58 M(-14.8%) |
| Sept 2020 | - | $3.21 M(+6.3%) | $13.59 M(-4.8%) |
| June 2020 | - | $3.02 M(+21.8%) | $14.28 M(+5.8%) |
| Mar 2020 | - | $2.48 M(-49.2%) | $13.51 M(+3.2%) |
| Dec 2019 | $12.17 M(+36.1%) | $4.88 M(+25.1%) | $13.09 M(+34.6%) |
| Sept 2019 | - | $3.90 M(+74.0%) | $9.73 M(+30.8%) |
| June 2019 | - | $2.24 M(+8.5%) | $7.43 M(-0.3%) |
| Mar 2019 | - | $2.07 M(+36.2%) | $7.45 M(-16.6%) |
| Dec 2018 | $8.94 M(-30.2%) | $1.52 M(-5.8%) | $8.94 M(-17.3%) |
| Sept 2018 | - | $1.61 M(-28.8%) | $10.81 M(-14.3%) |
| June 2018 | - | $2.26 M(-36.4%) | $12.62 M(-6.9%) |
| Mar 2018 | - | $3.55 M(+4.9%) | $13.55 M(+5.7%) |
| Dec 2017 | $12.81 M(-4.0%) | $3.39 M(-0.9%) | $12.81 M(+3.4%) |
| Sept 2017 | - | $3.42 M(+7.0%) | $12.39 M(+6.9%) |
| June 2017 | - | $3.19 M(+13.3%) | $11.59 M(+0.5%) |
| Mar 2017 | - | $2.82 M(-4.9%) | $11.54 M(-13.6%) |
| Dec 2016 | $13.35 M(-30.8%) | $2.96 M(+13.4%) | $13.35 M(-20.5%) |
| Sept 2016 | - | $2.61 M(-16.8%) | $16.79 M(-3.5%) |
| June 2016 | - | $3.14 M(-32.3%) | $17.39 M(-7.3%) |
| Mar 2016 | - | $4.64 M(-27.5%) | $18.77 M(-2.7%) |
| Dec 2015 | $19.29 M(-5.3%) | $6.40 M(+98.5%) | $19.29 M(+3.5%) |
| Sept 2015 | - | $3.22 M(-28.6%) | $18.64 M(-7.2%) |
| June 2015 | - | $4.51 M(-12.6%) | $20.08 M(-7.7%) |
| Mar 2015 | - | $5.16 M(-10.1%) | $21.76 M(+6.8%) |
| Dec 2014 | $20.38 M(-16.9%) | $5.74 M(+23.3%) | $20.38 M(+16.3%) |
| Sept 2014 | - | $4.66 M(-24.8%) | $17.52 M(-11.9%) |
| June 2014 | - | $6.19 M(+63.6%) | $19.89 M(-5.6%) |
| Mar 2014 | - | $3.78 M(+31.0%) | $21.07 M(-14.1%) |
| Dec 2013 | $24.51 M(+3.8%) | $2.89 M(-58.9%) | $24.51 M(-12.7%) |
| Sept 2013 | - | $7.02 M(-4.7%) | $28.08 M(+2.7%) |
| June 2013 | - | $7.37 M(+1.9%) | $27.33 M(+6.5%) |
| Mar 2013 | - | $7.23 M(+12.0%) | $25.67 M(+8.7%) |
| Dec 2012 | $23.61 M(+18.9%) | $6.46 M(+2.9%) | $23.61 M(-20.9%) |
| Sept 2012 | - | $6.27 M(+9.8%) | $29.86 M(+15.0%) |
| June 2012 | - | $5.71 M(+10.4%) | $25.97 M(+14.3%) |
| Mar 2012 | - | $5.17 M(-59.3%) | $22.71 M(+14.3%) |
| Dec 2011 | $19.86 M(-1.8%) | $12.70 M(+434.0%) | $19.86 M(-5.1%) |
| Sept 2011 | - | $2.38 M(-3.1%) | $20.92 M(+1.3%) |
| June 2011 | - | $2.45 M(+5.4%) | $20.64 M(+1.3%) |
| Mar 2011 | - | $2.33 M(-83.1%) | $20.38 M(+0.7%) |
| Dec 2010 | $20.23 M(+170.9%) | $13.76 M(+554.7%) | $20.23 M(<-9900.0%) |
| Sept 2010 | - | $2.10 M(-3.8%) | -$80.00 K(-102.4%) |
| June 2010 | - | $2.19 M(+0.0%) | $3.37 M(-36.6%) |
| Mar 2010 | - | $2.19 M(-133.3%) | $5.31 M(-28.9%) |
| Dec 2009 | $7.47 M(-62.2%) | -$6.55 M(-218.1%) | $7.47 M(-59.8%) |
| Sept 2009 | - | $5.55 M(+34.3%) | $18.58 M(+4.2%) |
| June 2009 | - | $4.13 M(-4.9%) | $17.83 M(+13.4%) |
| Mar 2009 | - | $4.34 M(-4.6%) | $15.72 M(+14.7%) |
| Dec 2008 | $19.77 M | $4.56 M(-5.1%) | $13.71 M(-45.5%) |
| Sept 2008 | - | $4.80 M(+138.1%) | $25.17 M(+11.6%) |
| June 2008 | - | $2.02 M(-13.6%) | $22.56 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $2.33 M(-85.4%) | $22.88 M(+0.2%) |
| Dec 2007 | $22.84 M(+0.9%) | $16.02 M(+630.6%) | $22.84 M(+0.5%) |
| Sept 2007 | - | $2.19 M(-6.3%) | $22.72 M(+1.3%) |
| June 2007 | - | $2.34 M(+2.0%) | $22.43 M(-0.3%) |
| Mar 2007 | - | $2.29 M(-85.6%) | $22.49 M(-14.1%) |
| Dec 2006 | $22.64 M(+13.9%) | $15.89 M(+734.6%) | $26.20 M(+86.8%) |
| Sept 2006 | - | $1.90 M(-20.9%) | $14.02 M(-17.4%) |
| June 2006 | - | $2.41 M(-59.9%) | $16.98 M(-14.5%) |
| Mar 2006 | - | $5.99 M(+61.3%) | $19.85 M(+24.3%) |
| Dec 2005 | $19.88 M(-1.0%) | $3.72 M(-23.6%) | $15.97 M(-8.5%) |
| Sept 2005 | - | $4.86 M(-7.8%) | $17.46 M(+2.6%) |
| June 2005 | - | $5.28 M(+149.5%) | $17.02 M(+19.2%) |
| Mar 2005 | - | $2.12 M(-59.4%) | $14.28 M(+1.2%) |
| Dec 2004 | $20.09 M(+190.2%) | $5.21 M(+17.6%) | $14.11 M(+30.7%) |
| Sept 2004 | - | $4.43 M(+74.6%) | $10.80 M(+33.1%) |
| June 2004 | - | $2.53 M(+30.3%) | $8.11 M(+10.7%) |
| Mar 2004 | - | $1.95 M(+2.8%) | $7.33 M(+5.9%) |
| Dec 2003 | $6.92 M(-14.1%) | $1.89 M(+9.0%) | $6.92 M(-5.7%) |
| Sept 2003 | - | $1.74 M(-0.7%) | $7.34 M(-3.1%) |
| June 2003 | - | $1.75 M(+13.6%) | $7.58 M(-3.8%) |
| Mar 2003 | - | $1.54 M(-33.4%) | $7.88 M(-2.2%) |
| Dec 2002 | $8.06 M(+23.6%) | $2.31 M(+17.1%) | $8.06 M(+14.9%) |
| Sept 2002 | - | $1.98 M(-3.7%) | $7.01 M(+5.9%) |
| June 2002 | - | $2.05 M(+19.2%) | $6.62 M(+2.0%) |
| Mar 2002 | - | $1.72 M(+35.8%) | $6.49 M(+0.6%) |
| Dec 2001 | $6.52 M(+23.9%) | $1.27 M(-19.9%) | $6.45 M(-1.5%) |
| Sept 2001 | - | $1.58 M(-17.5%) | $6.54 M(+5.1%) |
| June 2001 | - | $1.92 M(+14.2%) | $6.22 M(+10.8%) |
| Mar 2001 | - | $1.68 M(+23.3%) | $5.61 M(+6.6%) |
| Dec 2000 | $5.27 M(+19.7%) | $1.36 M(+7.8%) | $5.27 M(+3.2%) |
| Sept 2000 | - | $1.26 M(-3.6%) | $5.10 M(+3.3%) |
| June 2000 | - | $1.31 M(-1.5%) | $4.94 M(+4.4%) |
| Mar 2000 | - | $1.33 M(+10.8%) | $4.73 M(+7.5%) |
| Dec 1999 | $4.40 M(+22.2%) | $1.20 M(+9.1%) | $4.40 M(+10.0%) |
| Sept 1999 | - | $1.10 M(0.0%) | $4.00 M(+5.3%) |
| June 1999 | - | $1.10 M(+10.0%) | $3.80 M(+2.7%) |
| Mar 1999 | - | $1.00 M(+25.0%) | $3.70 M(0.0%) |
| Dec 1998 | $3.60 M(-2.7%) | $800.00 K(-11.1%) | $3.70 M(-5.1%) |
| Sept 1998 | - | $900.00 K(-10.0%) | $3.90 M(0.0%) |
| June 1998 | - | $1.00 M(0.0%) | $3.90 M(+2.6%) |
| Mar 1998 | - | $1.00 M(0.0%) | $3.80 M(+2.7%) |
| Dec 1997 | $3.70 M(+15.6%) | $1.00 M(+11.1%) | $3.70 M(0.0%) |
| Sept 1997 | - | $900.00 K(0.0%) | $3.70 M(+2.8%) |
| June 1997 | - | $900.00 K(0.0%) | $3.60 M(+5.9%) |
| Mar 1997 | - | $900.00 K(-10.0%) | $3.40 M(+6.3%) |
| Dec 1996 | $3.20 M(+10.3%) | $1.00 M(+25.0%) | $3.20 M(+10.3%) |
| Sept 1996 | - | $800.00 K(+14.3%) | $2.90 M(+11.5%) |
| June 1996 | - | $700.00 K(0.0%) | $2.60 M(-10.3%) |
| Mar 1996 | - | $700.00 K(0.0%) | $2.90 M(0.0%) |
| Dec 1995 | $2.90 M(+11.5%) | $700.00 K(+40.0%) | $2.90 M(+3.6%) |
| Sept 1995 | - | $500.00 K(-50.0%) | $2.80 M(-3.4%) |
| June 1995 | - | $1.00 M(+42.9%) | $2.90 M(+11.5%) |
| Mar 1995 | - | $700.00 K(+16.7%) | $2.60 M(0.0%) |
| Dec 1994 | $2.60 M(+30.0%) | $600.00 K(0.0%) | $2.60 M(-236.8%) |
| Sept 1994 | - | $600.00 K(-14.3%) | -$1.90 M(+280.0%) |
| June 1994 | - | $700.00 K(0.0%) | -$500.00 K(-155.6%) |
| Mar 1994 | - | $700.00 K(-117.9%) | $900.00 K(-55.0%) |
| Dec 1993 | $2.00 M(+42.9%) | -$3.90 M(-295.0%) | $2.00 M(-66.1%) |
| Sept 1993 | - | $2.00 M(-4.8%) | $5.90 M(+51.3%) |
| June 1993 | - | $2.10 M(+16.7%) | $3.90 M(+116.7%) |
| Mar 1993 | - | $1.80 M | $1.80 M |
| Dec 1992 | $1.40 M(+27.3%) | - | - |
| Dec 1991 | $1.10 M(+37.5%) | - | - |
| Dec 1990 | $800.00 K | - | - |
FAQ
- What is Fresh Tracks Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual SG&A year-on-year change?
- What is Fresh Tracks Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly SG&A year-on-year change?
- What is Fresh Tracks Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM SG&A year-on-year change?
What is Fresh Tracks Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of FRTX is $11.18 M
What is the all time high annual SG&A for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual selling, general & administrative expenses is $24.51 M
What is Fresh Tracks Therapeutics annual SG&A year-on-year change?
Over the past year, FRTX annual selling, general & administrative expenses has changed by -$3.25 M (-22.52%)
What is Fresh Tracks Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of FRTX is $1.64 M
What is the all time high quarterly SG&A for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly selling, general & administrative expenses is $16.02 M
What is Fresh Tracks Therapeutics quarterly SG&A year-on-year change?
Over the past year, FRTX quarterly selling, general & administrative expenses has changed by -$3.68 M (-69.14%)
What is Fresh Tracks Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of FRTX is -$686.86 M
What is the all time high TTM SG&A for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM selling, general & administrative expenses is $29.86 M
What is Fresh Tracks Therapeutics TTM SG&A year-on-year change?
Over the past year, FRTX TTM selling, general & administrative expenses has changed by -$700.44 M (-5157.89%)